CA2441832A1 - Proteines secretees humaines - Google Patents
Proteines secretees humaines Download PDFInfo
- Publication number
- CA2441832A1 CA2441832A1 CA002441832A CA2441832A CA2441832A1 CA 2441832 A1 CA2441832 A1 CA 2441832A1 CA 002441832 A CA002441832 A CA 002441832A CA 2441832 A CA2441832 A CA 2441832A CA 2441832 A1 CA2441832 A1 CA 2441832A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polypeptide
- referenced
- fragment
- cdna clone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention concerne des polypeptides sécrétés humains, ainsi que des molécules d'acides nucléiques isolés codant lesdits polypeptides, servant à diagnostiquer et à traiter des maladies et des affections auto-immunes. L'invention concerne également des anticorps qui fixent ces polypeptides, ainsi que des vecteurs, des cellules hôtes, des méthodes de recombinaison et de synthèse pour produire lesdits polynucléotides, polypeptides et/ou anticorps. L'invention concerne en outre des méthodes de criblage servant à identifier des agonistes et des antagonistes des polynucléotides et polypeptides de l'invention. Elle concerne enfin des méthodes et des compositions servant à inhiber ou stimuler la production et la fonction des polypeptides de l'invention.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27734001P | 2001-03-21 | 2001-03-21 | |
US60/277,340 | 2001-03-21 | ||
US30617101P | 2001-07-19 | 2001-07-19 | |
US60/306,171 | 2001-07-19 | ||
US33128701P | 2001-11-13 | 2001-11-13 | |
US60/331,287 | 2001-11-13 | ||
PCT/US2002/008278 WO2002102994A2 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2441832A1 true CA2441832A1 (fr) | 2002-12-27 |
Family
ID=27402891
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002441702A Abandoned CA2441702A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par l'homme |
CA002441840A Abandoned CA2441840A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
CA002441832A Abandoned CA2441832A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
CA002441397A Abandoned CA2441397A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
CA002441417A Abandoned CA2441417A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par les humains |
CA002441755A Abandoned CA2441755A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
CA002441416A Abandoned CA2441416A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002441702A Abandoned CA2441702A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par l'homme |
CA002441840A Abandoned CA2441840A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002441397A Abandoned CA2441397A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
CA002441417A Abandoned CA2441417A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par les humains |
CA002441755A Abandoned CA2441755A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
CA002441416A Abandoned CA2441416A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
Country Status (4)
Country | Link |
---|---|
EP (7) | EP1379132A4 (fr) |
AU (6) | AU2002363296A1 (fr) |
CA (7) | CA2441702A1 (fr) |
WO (7) | WO2002102994A2 (fr) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7196164B2 (en) | 1997-07-08 | 2007-03-27 | Human Genome Sciences, Inc. | Secreted protein HHTLF25 |
EP1000084A4 (fr) | 1997-07-08 | 2003-03-26 | Human Genome Sciences Inc | 123 proteines humaines secretees |
US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
AU757698C (en) | 1998-06-01 | 2004-04-08 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
EE200100372A (et) | 1999-01-15 | 2002-10-15 | Biogen, Incorporated | TWEAK-valgu ja TWEAK-valgu retseptori antagonistid ja nende kasutamine immuunhaiguste raviks |
US7291719B2 (en) | 2000-07-25 | 2007-11-06 | Genentech, Inc. | PRO4332 antibodies |
EP1666490A3 (fr) * | 2000-07-25 | 2006-11-02 | Genentech, Inc. | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci |
EP1364021A2 (fr) | 2000-10-31 | 2003-11-26 | Diadexus, Inc. | Compositions et methodes associees a des genes et a des proteines specifiques du colon |
US20020111302A1 (en) * | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
EP1573024A4 (fr) * | 2001-04-10 | 2007-08-29 | Agensys Inc | Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers |
US7164007B2 (en) | 2001-06-20 | 2007-01-16 | Genentech, Inc. | Anti-PR020044 antibodies |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
EP2287186B1 (fr) | 2001-09-06 | 2014-12-31 | Agensys, Inc. | Acide nucléique et protéine corréspondante designés par STEAP-1 utiles dans le traitement et la détection du cancer |
WO2003033727A1 (fr) | 2001-10-12 | 2003-04-24 | Yamanouchi Pharmaceutical Co., Ltd. | Procede de criblage d'un inhibiteur de la mort cellulaire |
EP1997512B1 (fr) | 2002-04-09 | 2013-12-04 | Biogen Idec MA Inc. | Procédés de traitement de conditions associées à TWEAK |
AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
WO2005019258A2 (fr) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions et methodes de traitement de maladies relatives au systeme immunitaire |
ES2339710T5 (es) | 2003-09-23 | 2017-10-05 | University Of North Carolina At Chapel Hill | Células que coexpresan vitamina K reductasa y proteína dependiente de vitamina K y uso de las mismas para mejorar la productividad de dicha proteína dependiente de vitamina K |
PL2189523T3 (pl) * | 2003-10-14 | 2012-05-31 | Baxalta Inc | Polipeptyd przekształcający epoksyd witaminy K VKORC1, obiekt działania leczniczego kumaryny i jej pochodnych |
EP1714154A2 (fr) * | 2004-02-03 | 2006-10-25 | Bayer HealthCare AG | Agents diagnostiques et therapeutiques pour des maladies associes a la glutamate carboxypeptidase (pgcp) plasmatique |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
MXPA06012187A (es) | 2004-04-22 | 2007-03-28 | Agensys Inc | Anticuerpos y moleculas derivadas de estas que se enlazan a las proteinas steap-1. |
US8759305B2 (en) * | 2004-09-01 | 2014-06-24 | Dynavax Technologies Corporation | Methods and compositions for inhibition of innate immune responses and autoimmunity |
CA2579705A1 (fr) * | 2004-09-07 | 2006-03-16 | Telethon Institute For Child Health Research | Methode de diagnostic et/ou de prediction du developpement d'une affection allergique |
CA2579349A1 (fr) * | 2004-09-07 | 2006-03-16 | Telethon Institute For Child Health Research | Agents pour le traitement ou la prevention d'une affection allergique |
AU2006214179A1 (en) | 2005-02-17 | 2006-08-24 | Biogen Idec Ma Inc. | Treating neurological disorders |
MX349285B (es) | 2005-02-28 | 2017-07-20 | Baxalta Inc | Co-expresion recombinante de reductasa de epoxido de vitamina k subunidad 1 para mejorar la expresion de proteina dependiente de vitamina k. |
EP1861499A4 (fr) | 2005-03-15 | 2008-09-03 | Univ North Carolina | Procédés et compositions pour la production de protéines actives dépendantes de la vitamine k |
ES2432564T3 (es) | 2005-05-10 | 2013-12-04 | Biogen Idec Ma Inc. | Tratamiento y evaluación de trastornos inflamatorios |
WO2006138219A2 (fr) * | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Procedes d'evaluation de patients |
GB2445882B (en) * | 2005-09-01 | 2011-02-23 | Florey Howard Inst | Prophylactic and therapeutic agents and compositions and uses therefor and methods for determining the presence or severity of neuronal damage |
GB0521488D0 (en) * | 2005-10-21 | 2005-11-30 | Ares Trading Sa | Integral membrane protein |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
US8436147B2 (en) | 2006-10-27 | 2013-05-07 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
EP2083864A4 (fr) | 2006-11-07 | 2010-12-08 | Merck Sharp & Dohme | Antagonistes de pcsk9 |
US8093222B2 (en) * | 2006-11-27 | 2012-01-10 | Isis Pharmaceuticals, Inc. | Methods for treating hypercholesterolemia |
EP2142217B1 (fr) * | 2007-03-27 | 2014-11-05 | Merck Sharp & Dohme Corp. | Procédé de détection de pcsk9 secrétée, autogénérée |
JOP20080381B1 (ar) | 2007-08-23 | 2023-03-28 | Amgen Inc | بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9) |
EP2209896B1 (fr) | 2007-10-26 | 2017-03-01 | Dynavax Technologies Corporation | Procédés et compositions pour inhiber les réponses immunitaires et l'auto-immunité |
US8017573B2 (en) * | 2007-11-30 | 2011-09-13 | Siemens Healthcare Diagnostics Inc. | Adiponectin receptor fragments and methods of use |
AR070315A1 (es) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | Anticuerpos 1b20 antagonistas de pcsk9 |
AR070316A1 (es) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9) |
US8748115B2 (en) | 2008-12-12 | 2014-06-10 | Merck Sharp & Dohme Corp. | PCSK9 immunoassay |
JP2013509191A (ja) | 2009-10-30 | 2013-03-14 | メルク・シャープ・エンド・ドーム・コーポレイション | Ax1およびax189pcsk9アンタゴニストおよびバリアント |
CN102639150A (zh) | 2009-10-30 | 2012-08-15 | 默沙东公司 | Ax213和ax132 pcsk9拮抗剂和变体 |
EP2582398B1 (fr) | 2010-06-16 | 2016-04-13 | Dynavax Technologies Corporation | Méthodes et traitements a l'aide d'inhibiteurs de tlr7 et/ tlr9 |
US8871737B2 (en) | 2010-09-22 | 2014-10-28 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
WO2012088222A2 (fr) | 2010-12-21 | 2012-06-28 | The University Of North Carolina At Chapel Hill | Procédés et compositions pour la production de protéines actives dépendantes de la vitamine k |
WO2013096680A1 (fr) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Analogues de nucléotide phosphorothioate substitués |
EP2828277A1 (fr) | 2012-03-21 | 2015-01-28 | Vertex Pharmaceuticals Incorporated | Formes solides d'un promédicament nucléotidique thiophosphoramidate |
WO2013142157A1 (fr) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Combinaisons pharmaceutiques comprenant un analogue thionucléotidique |
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US9067998B1 (en) | 2014-07-15 | 2015-06-30 | Kymab Limited | Targeting PD-1 variants for treatment of cancer |
US9045545B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision medicine by targeting PD-L1 variants for treatment of cancer |
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US9045548B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US8883157B1 (en) | 2013-12-17 | 2014-11-11 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9051378B1 (en) | 2014-07-15 | 2015-06-09 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
US9914769B2 (en) | 2014-07-15 | 2018-03-13 | Kymab Limited | Precision medicine for cholesterol treatment |
US8945560B1 (en) | 2014-07-15 | 2015-02-03 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US9023359B1 (en) | 2014-07-15 | 2015-05-05 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9034332B1 (en) | 2014-07-15 | 2015-05-19 | Kymab Limited | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US9682218B2 (en) | 2013-12-23 | 2017-06-20 | Carefusion 2200, Inc. | Pleurodesis device and method |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
US9150660B1 (en) | 2014-07-15 | 2015-10-06 | Kymab Limited | Precision Medicine by targeting human NAV1.8 variants for treatment of pain |
US9139648B1 (en) | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
WO2018083248A1 (fr) | 2016-11-03 | 2018-05-11 | Kymab Limited | Anticorps, combinaisons comprenant des anticorps, biomarqueurs, utilisations et procédés |
CA3048479A1 (fr) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Edition genique de pcsk9 |
BR112019018767A2 (pt) | 2017-04-03 | 2020-05-05 | Hoffmann La Roche | anticorpos, molécula de ligação ao antígeno biespecífica, um ou mais polinucleotídeos isolados, um ou mais vetores, célula hospedeira, método para produzir um anticorpo, composição farmacêutica, usos, método para tratar uma doença em um indivíduo e invenção |
CN110719968A (zh) * | 2017-06-22 | 2020-01-21 | 宝洁公司 | 包括水溶性层和气相沉积无机涂层的膜 |
CN110709174A (zh) | 2017-06-22 | 2020-01-17 | 宝洁公司 | 包括水溶性层和气相沉积有机涂层的膜 |
US20230158174A1 (en) | 2020-04-09 | 2023-05-25 | Verve Therapeutics, Inc. | Chemically modified guide rnas for genome editing with cas9 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100236393B1 (ko) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
WO2000004140A1 (fr) * | 1998-07-15 | 2000-01-27 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
WO2002026931A2 (fr) * | 2000-09-25 | 2002-04-04 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
US5858716A (en) * | 1997-05-30 | 1999-01-12 | Smithkline Beecham Corporation | H2CAA71 polynucleotides |
-
2002
- 2002-03-19 AU AU2002363296A patent/AU2002363296A1/en not_active Abandoned
- 2002-03-19 CA CA002441702A patent/CA2441702A1/fr not_active Abandoned
- 2002-03-19 AU AU2002320013A patent/AU2002320013A1/en not_active Abandoned
- 2002-03-19 WO PCT/US2002/008278 patent/WO2002102994A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441840A patent/CA2441840A1/fr not_active Abandoned
- 2002-03-19 EP EP02760994A patent/EP1379132A4/fr not_active Withdrawn
- 2002-03-19 AU AU2002326293A patent/AU2002326293A1/en not_active Abandoned
- 2002-03-19 EP EP02780789A patent/EP1423134A2/fr not_active Withdrawn
- 2002-03-19 AU AU2002332391A patent/AU2002332391A1/en not_active Abandoned
- 2002-03-19 EP EP02723499A patent/EP1379264A4/fr not_active Withdrawn
- 2002-03-19 WO PCT/US2002/009785 patent/WO2002095010A2/fr not_active Application Discontinuation
- 2002-03-19 WO PCT/US2002/008279 patent/WO2002090526A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441832A patent/CA2441832A1/fr not_active Abandoned
- 2002-03-19 CA CA002441397A patent/CA2441397A1/fr not_active Abandoned
- 2002-03-19 WO PCT/US2002/008124 patent/WO2003004622A2/fr not_active Application Discontinuation
- 2002-03-19 AU AU2002354719A patent/AU2002354719A1/en not_active Abandoned
- 2002-03-19 EP EP02782476A patent/EP1414845A4/fr not_active Withdrawn
- 2002-03-19 AU AU2002324424A patent/AU2002324424A1/en not_active Abandoned
- 2002-03-19 EP EP02749512A patent/EP1381622A2/fr not_active Withdrawn
- 2002-03-19 WO PCT/US2002/008277 patent/WO2003038063A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441417A patent/CA2441417A1/fr not_active Abandoned
- 2002-03-19 CA CA002441755A patent/CA2441755A1/fr not_active Abandoned
- 2002-03-19 WO PCT/US2002/008123 patent/WO2002102993A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441416A patent/CA2441416A1/fr not_active Abandoned
- 2002-03-19 EP EP02759068A patent/EP1404702A4/fr not_active Withdrawn
- 2002-03-19 EP EP02799146A patent/EP1390390A4/fr not_active Withdrawn
- 2002-03-19 WO PCT/US2002/008276 patent/WO2002076488A1/fr not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2441832A1 (fr) | Proteines secretees humaines | |
CA2442777A1 (fr) | Proteines secretees par l'etre humain | |
CA2393616A1 (fr) | Acides nucleiques, proteines et anticorps | |
US6380362B1 (en) | Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use | |
EP0428602B1 (fr) | Polypetides et adn les encodant | |
Crovella et al. | Primate β-defensins-structure, function and evolution | |
CA2395885A1 (fr) | Acides nucleiques, proteines et anticorps | |
CA2283678A1 (fr) | 28 proteines secretees par l'homme | |
JP2001509030A (ja) | Fcレセプターおよびポリペプチド | |
JP2002502600A (ja) | ヒトセリンプロテアーゼおよびセルピンポリペプチド | |
EP0998490A2 (fr) | Proteines secretees et polynucleotides les codant | |
EP1379648A1 (fr) | Adn complementaires humains pleine longueur codant des proteines potentiellement secretees | |
JP2003525566A (ja) | 125個のヒト分泌タンパク質 | |
WO1998055614A2 (fr) | Proteines secretees et polynucleotides codant ces proteines | |
EP1283214B1 (fr) | Nouvelles collectines | |
CA2324492A1 (fr) | Proteines secretees et polynucleotides les codant | |
EP0240224A2 (fr) | Analogue d'alpha interféron | |
JP4233757B2 (ja) | 尋常よもぎ(Artemisia vulgaris(mugwort))花粉の組換え主要アレルゲン | |
JPH10504456A (ja) | C5aレセプターをコードするポリヌクレオチド | |
AU2001235625B2 (en) | Partners of PTB1 domain of FE65, preparation and uses | |
EP0971954A2 (fr) | Proteines secretees et polynucleotides les codant | |
JP3379952B2 (ja) | オーレオバシジン感受性遺伝子 | |
CA2318303A1 (fr) | Proteines secretees et polynucleotides les codant | |
US20040110194A1 (en) | Genes regulated by human cytokines | |
CA2291485A1 (fr) | Proteines secretees et polynucleotides codant ces proteines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |